Xeris gets $41M for shelf-stable glucagon pen
The New Normal: Glucagon Ready to Go - Taking Control Of Your Diabetes®
FDA Approves Potentially Life Saving GVOKE: Xeris' Ready-to-Use Glucagon
Gvoke HypoPen – Nadia's Pharmacy
What Is Gvoke® (glucagon injection)? | Healthcare Professionals
Gvoke®
Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar
Ready-to-Use Glucagon Rescue Pen Under FDA Review for Severe Hypoglycemia Tx - MPR
Ready-to-use glucagon rescue pen - Type 1 and LADA - TuDiabetes Forum
S-1
FDA OKs Easy-to-Use Glucagon Rescue Pen for Hypos in Diabetes
Xeris: Looking For Entry Before PDUFA (NASDAQ:XERS) | Seeking Alpha
Xeris Submits Glucagon Rescue Pen to FDA: A Dramatically Easier and Faster Treatment for Severe Hypoglycemia
Breaking: New Glucagon Pen Released, Targets Emergency Hypoglycemia : 2021 Reports : Report Library : Publications : Juvenile Diabetes Cure Alliance (JDCA)
Xeris Poised to Bring New Glucagon Options to Market – Diabetes Daily
Glucagon
AN ASSESSMENT OF USABILITY AND DRUG PREPARATION TIME FOR A READY-TO-USE LIQUID GLUCAGON RESCUE PEN
FDA Approves First Ready-to-Use Glucagon Pen - Diabetic Nation
Glucagon Rescue Meds and PocketCard - Diabetes Education Services
789 Important Things to Know About Gvoke HypoPen® (glucagon injection) — JUICEBOX PODCAST
What Is Gvoke® (glucagon injection)? | Healthcare Professionals
Expanding Glucagon Access and Use in the Prehospital Setting - JEMS: EMS, Emergency Medical Services - Training, Paramedic, EMT News
Gvoke®
FDA Approves Xeris Pharmaceuticals' Glucagon to Treat Severe Hypoglycemia - JDRF
